EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective efficacy of a candidate live attenuated vaccine derived from the SD-R strain of lineage 1 porcine reproductive and respiratory syndrome virus against a lethal challenge with HP-PRRSV HuN4 in piglets

Hongliang Zhang iD, Chao Li, Hu Xu, Bangjun Gong, Wansheng Li, Zhenyang Guo, Lirun Xiang, Qi Sun, Jing Zhao, Jinmei Peng, Qian Wang, Guohui Zhou und 4 weitere

Microbiology Spectrum · 12.12.2023 · 11 (6)

DOI: 10.1128/spectrum.01984-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 12.12.2023. Verfasst von Hongliang Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Harbin, China. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Porcine Reproductive and Respiratory Syndrome, Viral Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST| Natural Science Foundation of Heilongjiang Province (Heilongjiang Natural Science Foundation), MOST | National Natural Science Foundation of China (NSFC), National Center of Technology Innovation for pigs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome virus (PRRSV) is an important pathogen endangering the swine industry worldwide. Our previous study confirmed that the live attenuated vaccine SD-R strain could provide broad cross-protection against homologous and heterologous NADC30-like viruses. However, it is unclear whether SD-R can provide protection for piglets against HP-PRRSV. In the present study, 4-week-old PRRSV-free piglets were vaccinated intramuscularly with 10 6.2 TCID 50 of SD-R and then challenged intramuscularly (2 mL) and intranasally (2 mL) with HP-PRRSV HuN4 (1 × 10 5.0 TCID 50 /mL). The results showed that two of five piglets died in the HuN4 challenge group and five of five immunized piglets survived in the immune challenge group. Five piglets in the HuN4 challenge group had a fever for 6–12 days and showed obvious clinical symptoms, but 3 of 5 piglets had a fever for only 1 day at 5 days post inoculation, and only 1 of the 5 piglets in the immune challenge group had a cough. Compared to challenged control piglets, vaccinated piglets had significantly improved daily weight gain and obviously alleviated pathological lesions. Furthermore, piglets immunized with SD-R had reduced thymus atrophy caused by HP-PRRSV HuN4. These results demonstrate that the lineage 1 PRRSV attenuated vaccine SD-R strain provides protection against lethal HP-PRRSV HuN4 challenge. As such, it is a promising vaccine candidate for use against PRRSV infection. IMPORTANCE Both highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) and NADC30-like PRRSV have caused tremendous economic losses to the Chinese pig industry. In this study, a good challenge model was established to evaluate the protection afforded by the candidate SD-R vaccine against infection with a representative HP-PRRSV strain (HuN4). The control piglets in the challenge experiment displayed obvious clinical symptoms of PRRSV infection, with a mortality rate up to 40%. In contrast, all the piglets in the vaccinated challenged group survived, and only some pigs had transient fever. The daily gain of SD-R immunized group piglets was significantly increased, and the pathological changes were significantly reduced. In addition, the viral replication levels in the serum of the immunized group were significantly lower than those of the challenged control group. The live attenuated vaccine SD-R strain can provide protection against HP-PRRSV challenge, indicating that the SD-R strain is a promising vaccine candidate for use in the swine industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine respiratory and reproductive syndrome virusPorcine Reproductive and Respiratory SyndromeViral VaccinesSwineAnimalsVaccines, AttenuatedAntibodies, Viral

Stichwörter der Autor:innen

HP-PRRSV HuN4SD-Rattenuated vaccinecross-protection efficacylineage 1

Substanzen

Vaccines, AttenuatedViral VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Harbin, China.

ORCID-Profile: Hongliang Zhang, Yan-Dong Tang, Tongqing An, Zhi-Jun Tian

Förderung

  • MOST| Natural Science Foundation of Heilongjiang Province (Heilongjiang Natural Science Foundation)
  • MOST | National Natural Science Foundation of China (NSFC)
  • National Center of Technology Innovation for pigs

Zitieren

APA

Zhang, H., Li, C., Xu, H., Gong, B., Li, W., Guo, Z., Xiang, L., Sun, Q., Zhao, J., Peng, J., Wang, Q., Zhou, G., Tang, Y. D., An, T., Cai, X. H., & Tian, Z. J. (2023). Protective efficacy of a candidate live attenuated vaccine derived from the SD-R strain of lineage 1 porcine reproductive and respiratory syndrome virus against a lethal challenge with HP-PRRSV HuN4 in piglets. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.01984-23

Vancouver

Zhang H, Li C, Xu H, Gong B, Li W, Guo Z, et al. Protective efficacy of a candidate live attenuated vaccine derived from the SD-R strain of lineage 1 porcine reproductive and respiratory syndrome virus against a lethal challenge with HP-PRRSV HuN4 in piglets. Microbiology Spectrum. 2023;11(6). doi:10.1128/spectrum.01984-23

BibTeX
@article{Zhang2023,
  author = {Zhang, Hongliang and Li, Chao and Xu, Hu and Gong, Bangjun and Li, Wansheng and Guo, Zhenyang and Xiang, Lirun and Sun, Qi and Zhao, Jing and Peng, Jinmei and Wang, Qian and Zhou, Guohui and Tang, Yan-Dong and An, Tongqing and Cai, Xue-Hui and Tian, Zhi-Jun},
  title = {Protective efficacy of a candidate live attenuated vaccine derived from the SD-R strain of lineage 1 porcine reproductive and respiratory syndrome virus against a lethal challenge with HP-PRRSV HuN4 in piglets},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {6},
  doi = {10.1128/spectrum.01984-23}
}
Kostenlos starten →